These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 12230886)
21. Adenoviral E1A suppresses secretory leukoprotease inhibitor and elafin secretion in human alveolar epithelial cells and bronchial epithelial cells. Higashimoto Y; Yamagata Y; Iwata T; Ishiguchi T; Okada M; Masuda M; Satoh H; Itoh H Respiration; 2005; 72(6):629-35. PubMed ID: 16355004 [TBL] [Abstract][Full Text] [Related]
22. Establishment of a melanogenesis regulation assay system using a fluorescent protein reporter combined with the promoters for the melanogenesis-related genes in human melanoma cells. Lin CC; Yang CH; Lin YJ; Chiu YW; Chen CY Enzyme Microb Technol; 2015 Jan; 68():1-9. PubMed ID: 25435499 [TBL] [Abstract][Full Text] [Related]
23. SKALP/elafin: an elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence, and evidence for transglutaminase cross-linking. Molhuizen HO; Alkemade HA; Zeeuwen PL; de Jongh GJ; Wieringa B; Schalkwijk J J Biol Chem; 1993 Jun; 268(16):12028-32. PubMed ID: 7685029 [TBL] [Abstract][Full Text] [Related]
24. Identification of a conserved cluster of skin-specific genes encoding secreted proteins. Moffatt P; Salois P; St-Amant N; Gaumond MH; Lanctôt C Gene; 2004 Jun; 334():123-31. PubMed ID: 15256262 [TBL] [Abstract][Full Text] [Related]
25. SKALP/elafin gene polymorphisms are not associated with pustular forms of psoriasis. Kuijpers AL; Pfundt R; Zeeuwen PL; Molhuizen HO; Mariman EC; van de Kerkhof PC; Schalkwijk J Clin Genet; 1998 Jul; 54(1):96-101. PubMed ID: 9727750 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of a range of anti-proliferative assays for the preclinical screening of anti-psoriatic drugs: a comparison of colorimetric and fluorimetric assays with the thymidine incorporation assay. George SE; Anderson RJ; Cunningham A; Donaldson M; Groundwater PW Assay Drug Dev Technol; 2010 Jun; 8(3):389-400. PubMed ID: 20482335 [TBL] [Abstract][Full Text] [Related]
27. Development of Tyrosinase Promoter-Based Fluorescent Assay for Screening of Anti-melanogenic Agents. Lee J; Lee S; Lee B; Roh K; Park D; Jung E Biol Pharm Bull; 2015; 38(10):1542-7. PubMed ID: 26179334 [TBL] [Abstract][Full Text] [Related]
28. Cellular genomic reporter assays for screening and evaluation of inducers of fetal hemoglobin. Vadolas J; Wardan H; Orford M; Williamson R; Ioannou PA Hum Mol Genet; 2004 Jan; 13(2):223-33. PubMed ID: 14645208 [TBL] [Abstract][Full Text] [Related]
29. Usefulness of double gene construct for rapid identification of transgenic mice exhibiting tissue-specific gene expression. Sato M; Watanabe T; Oshida A; Nagashima A; Miyazaki JI; Kimura M Mol Reprod Dev; 2001 Dec; 60(4):446-56. PubMed ID: 11746955 [TBL] [Abstract][Full Text] [Related]
30. A role for mitogen-activated protein kinase activation by integrins in the pathogenesis of psoriasis. Haase I; Hobbs RM; Romero MR; Broad S; Watt FM J Clin Invest; 2001 Aug; 108(4):527-36. PubMed ID: 11518726 [TBL] [Abstract][Full Text] [Related]
31. Differential effects of detergents on keratinocyte gene expression. van Ruissen F; Le M; Carroll JM; van der Valk PG; Schalkwijk J J Invest Dermatol; 1998 Apr; 110(4):358-63. PubMed ID: 9540975 [TBL] [Abstract][Full Text] [Related]
32. The Mad1 transcription factor is a novel target of activin and TGF-beta action in keratinocytes: possible role of Mad1 in wound repair and psoriasis. Werner S; Beer HD; Mauch C; Lüscher B; Werner S Oncogene; 2001 Nov; 20(51):7494-504. PubMed ID: 11709721 [TBL] [Abstract][Full Text] [Related]
33. Parakeratosis in skin is associated with loss of inhibitor of differentiation 4 via promoter methylation. Ruchusatsawat K; Wongpiyabovorn J; Protjaroen P; Chaipipat M; Shuangshoti S; Thorner PS; Mutirangura A Hum Pathol; 2011 Dec; 42(12):1878-87. PubMed ID: 21663940 [TBL] [Abstract][Full Text] [Related]
34. In vivo detection of human vascular endothelial growth factor promoter activity in transgenic mouse skin. Kishimoto J; Ehama R; Ge Y; Kobayashi T; Nishiyama T; Detmar M; Burgeson RE Am J Pathol; 2000 Jul; 157(1):103-10. PubMed ID: 10880381 [TBL] [Abstract][Full Text] [Related]
35. WISH cell line: from the antiviral system to a novel reporter gene assay to test the potency of human IFN-α and IFN-β. Bürgi Mde L; Prieto C; Etcheverrigaray M; Kratje R; Oggero M; Bollati-Fogolín M J Immunol Methods; 2012 Jul; 381(1-2):70-4. PubMed ID: 22549076 [TBL] [Abstract][Full Text] [Related]
36. Improved technique for detection of enhanced green fluorescent protein in transgenic mice. Shariatmadari R; Sipilä PP; Huhtaniemi IT; Poutanen M Biotechniques; 2001 Jun; 30(6):1282-5. PubMed ID: 11414219 [TBL] [Abstract][Full Text] [Related]
37. Altered expression of keratinocyte growth factor and its receptor in psoriasis. Finch PW; Murphy F; Cardinale I; Krueger JG Am J Pathol; 1997 Dec; 151(6):1619-28. PubMed ID: 9403712 [TBL] [Abstract][Full Text] [Related]
38. Elafin is induced in epidermis in skin disorders with dermal neutrophilic infiltration: interleukin-1 beta and tumour necrosis factor-alpha stimulate its secretion in vitro. Tanaka N; Fujioka A; Tajima S; Ishibashi A; Hirose S Br J Dermatol; 2000 Oct; 143(4):728-32. PubMed ID: 11069448 [TBL] [Abstract][Full Text] [Related]
39. Green fluorescent protein is a suitable reporter of tumor hypoxia despite an oxygen requirement for chromophore formation. Vordermark D; Shibata T; Brown JM Neoplasia; 2001; 3(6):527-34. PubMed ID: 11774035 [TBL] [Abstract][Full Text] [Related]
40. The effects of oral liarozole on epidermal proliferation and differentiation in severe plaque psoriasis are comparable with those of acitretin. Kuijpers AL; Van Pelt JP; Bergers M; Boegheim PJ; Den Bakker JE; Siegenthaler G; Van de Kerkhof PC; Schalkwijk J Br J Dermatol; 1998 Sep; 139(3):380-9. PubMed ID: 9988537 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]